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2013–2014 Influenza Season E-brief
Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can 
cause mild to severe illness, and at times can lead to death. Routine annual influenza 
vaccination of all persons aged 6 months and older continues to be recommended and 
some people, such as older people, young children, and people with certain health 
conditions, are at high risk for serious flu complications. The best way to prevent the flu 
is by getting vaccinated each year.  For further detail, access the CDC’s website page for 
the 2013–2014 Influenza Season.
Recap of the 2012–2013 Flu Season
Last flu season was a stark reminder of how unpredictable and severe influenza can be. 
There were high influenza hospitalization rates, especially in the elderly. CDC saw the 
highest proportion of persons 65 and older hospitalized for flu since tracking began 
during the 2005–06 season. During the 2012–2013 influenza season, more than 150  
flu-related pediatric deaths were reported. More information about pediatric deaths 
since the 2004–2005 flu season is available in the interactive pediatric death web 
application. U.S. public health officials are encouraging the public to prepare for the 
upcoming flu season by getting vaccinated. For more details, please visit 2012–2013 Flu 
Season Drawing to a Close on the CDC website.
Available Vaccine Products and Indications
CDC recommends that people get vaccinated against influenza as soon as the 2013–
2014 flu season vaccine becomes available in their community. A variety of influenza 
vaccine products are available, including five newly approved vaccines.  Where more 
than one type of vaccine is appropriate and available, there is no preference for the use 
of an influenza vaccine product over another.  For a detailed summary of the Advisory 
Committee on Immunization Practices (ACIP) recommendations for the 2013-2014 flu 
season in the United States, please visit here.( Hyperlink here with: http://www.cdc.gov/
flu/professionals/acip/2013-summary-recommendations.htm 
For the 2013–2014 influenza season, manufacturers have projected that they will 
produce between 135 million and 139 million doses of influenza vaccine for use in 
the United States. An estimated 30 million to 32 million of these doses will be the 
quadrivalent flu vaccine. The remainder will be the trivalent flu vaccine.   Additional 
details about vaccine supply and distribution is available on CDC’s Seasonal Influenza 
webpage under Questions and Answers.
Primary Changes and Updates in Vaccine Recommendations 
2013–14 U.S. trivalent influenza vaccines will contain an A/California/7/2009 (H1N1)-
like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/
Victoria/361/2011, and a B/Massachusetts/2/2012-like virus. Quadrivalent vaccines will 
include an additional vaccine virus, a B/Brisbane/60/2008-like virus.
Several new, recently-licensed vaccines will be available for the 2013–14 season and 
are acceptable alternatives to other licensed vaccines indicated for their respective age 
groups when otherwise appropriate. For the table of vaccine options approved for  
the 2013–14 season, please see Summary Recommendations .
National Influenza Vaccination Week 
(NIVW) is a national observance that 
was established to highlight the 
importance of continuing influenza 
vaccination.
NIVW is December 8–14, 2013.




Access to new information on the CDC website
Vaccine Information Statements (VISs): Information sheets produced by the CDC that 
explain both the benefits and risks of a vaccine to vaccine recipients. Click here for latest 
information about VISs currently under development or newly released.
Seasonal Influenza Vaccination Resources for Health Professionals: Information for 
the 2013–2014 Influenza Season.
FluView: A Weekly Influenza Surveillance Report prepared by the Influenza Division (CDC). 
All data are preliminary and may change as more reports are received.
Seasonal Influenza Vaccine & Total Doses Distributed: This table reflects the cumulative 
weekly total number of seasonal influenza vaccine doses distributed in the US as 
reported to CDC by influenza vaccine manufacturers and selected distributors. Currently, 
manufacturers project 135–139 million doses of flu vaccine to be produced for the  
2013–14 season.
Seasonal Flu Vaccine Safety and Pregnant Women: Questions and Answers
Recent highlights from the Morbidity and Mortality Weekly Report (MMWR)
National Influenza Vaccination Disparities Partnership: The National Influenza 
Vaccination Disparities Partnership (NIVDP) is comprised of multisector partners who work 
to promote vaccination among underserved populations including African Americans, 
Hispanics, and American Indians/Alaska Natives. The partnership and InFLUential News are 
supported by the Centers for Disease Control and Prevention (CDC). Monthly InFLUential 
partner newsletters and materials for grassroots outreach are available here.
Frequently Asked Questions about the 2013–2014 
Influenza Season
What sort of flu season is expected this year? Flu seasons are unpredictable in a 
number of ways. Although epidemics of flu happen every year, the timing, severity, and 
the length of the season varies from one year to another. 
Who should get vaccinated this season? Everyone who is at least 6 months of age 
should get the flu vaccination with rare exception and while everyone should get a flu 
vaccine each flu season, it is especially important that certain people get vaccinated either 
because they are at high risk of having serious flu-related complications or because they 
live with or care for people at high risk for developing flu-related complications.  
High risk groups include:
•	 Pregnant Women
•	 Children younger than 5, but especially children younger than 2 years old
•	 People 50 years of age and older
•	 People of any age with chronic medical conditions
•	 People who live in nursing homes and other long-term care facilities
•	 People who live with or care for those at high risk for complications from  
flu including:
 – Health care workers
 – Household contacts of persons at high risk for complications from the flu
 – Household contacts and out of home caregivers of children less than  
6 months of age as these children are too young to be vaccinated.
When should I get vaccinated? CDC recommends that people should begin getting 
vaccinated soon after vaccine becomes available, ideally by October, to ensure that as 
many people as possible are protected before flu season begins. However, as long as  
flu viruses are circulating, vaccination should continue to be offered throughout the  
flu season, even in January or later. 
At Your Fingertips
CDC provides you with FREE online print 
materials, resources including print, 
audio, video and digital tools, images and 
mobile content. Select print materials are 
available in hard copy, FREE to order.
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It takes about two weeks after vaccination for antibodies to develop in the body and provide protection against the flu.
What about pregnant women? Pregnant women are at high 
risk for serious complications from influenza. Getting a flu shot 
protects pregnant women from the flu and can decrease the 
baby’s risk of getting the flu for up to 6 months after birth. 
However, the nasal spray vaccine is not recommended for use 
in pregnant women.
Where can I get a flu vaccine? Flu vaccines are offered in 
many locations, including doctor’s offices, clinics, health 
departments, pharmacies and college health centers, as well 
as by many employers, and even in some schools. If you don’t 
have a regular doctor or nurse, you can get a flu vaccine at a 
health department, pharmacy, urgent care clinic, and often 
your school, college health center, or workplace.  Click here for 
a list of flu clinics in your area that offer the vaccine.
Why do I need a flu vaccine every year? Flu viruses are 
constantly changing and flu vaccines may be updated from one 
season to the next to protect against the viruses.  In addition, 
an annual vaccination is needed for optimal protection as a 
person’s immune protection declines over time.
When will flu activity begin and when will it peak? The 
timing of flu is very unpredictable and can vary from season to 
season. Flu activity most commonly peaks in the U.S. in January 
or February. However, seasonal flu activity can begin as early 
as October and continue to occur as late as May.  During the 
2012–2013 season, influenza activity started about 4 weeks 
early and was intense. Influenza-like-illness (ILI) rose quickly 
to well above the baseline of expected activity and remained 
elevated for 15 consecutive weeks, making the 2012–13 season 
slightly longer than average. For the past 10 seasons, ILI has 
remained above baseline an average of 12 consecutive weeks 
with a range of one week to 16 weeks.  It is not possible to 
predict how mild or severe the Flu Season will be in 2013–2014.
What should I do to prepare for this flu season? It is good 
practice to get the flu vaccine soon after it is available, ideally 
by October, so that as many people as possible are vaccinated 
before influenza begins spreading in their community.                
In addition, you can take everyday preventive steps like staying 
away from sick people and washing your hands to reduce the 
spread of germs. If you are sick with flu, stay home from work or 
school to prevent spreading influenza to others.
Is there treatment for the flu? Yes. If you get sick, there are 
drugs that can treat flu illness. They are called antiviral drugs 
and they can make your illness milder and make you feel better 
faster. They also can prevent serious flu-related complications, 
like pneumonia. For more information about antiviral drugs, 
visit Treatment (Antiviral Drugs).
Influenza Vaccine
What kind of vaccines will be available in the United States 
for 2013–2014? A number of different manufacturers produce 
trivalent (three component) influenza vaccines for the U.S. 
market, including intramuscular (IM), intradermal, and nasal 
spray vaccines. See Key Facts About Seasonal Flu Vaccine for 
more information about the different types of vaccine available 
in the United States.
Most of the flu vaccine offered for the 2013–2014 season will 
be trivalent (three component). Some seasonal flu vaccines will 
be formulated to protect against four flu viruses (quadrivalent 
flu vaccines) and will be available as well according to 
manufacturers. All nasal spray vaccines are expected to be 
quadrivalent, however, this makes up only a small portion of 
total vaccine availability.
Where more than one type of vaccine is appropriate and 
available, no preferential recommendation is made for use of 
any influenza vaccine product over another. More information 
about influenza vaccines is available at Preventing Seasonal Flu 
With Vaccination.
How effective is the flu vaccine?  Recent studies show 
vaccine can reduce the risk of flu illness by about 60% among 
the overall population during seasons when most circulating 
flu viruses are like the viruses the flu vaccine is designed to 
protect against. Preliminary results for the 2012-2013 flu 
season are consistent with this Vaccine Effectiveness (VE) . 
CDC’s mid-season VE estimates were published on February 
21, 2013, in a Morbidity and Mortality Weekly Report entitled: 
Interim Adjusted Estimates of Seasonal Influenza Vaccine 
Effectiveness—United States, February 2013.
How long does a flu vaccine protect me from getting the 
flu? Multiple studies conducted over different seasons and 
across vaccine types and influenza virus subtypes have shown 
that the body’s immunity to influenza viruses (acquired either 
through natural infection or vaccination) declines over time. 
The decline in antibodies is influenced by several factors, 
including the antigen used in the vaccine, age of the person 
being vaccinated, and the person’s general health. When most 
healthy people with regular immune systems are vaccinated, 
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their bodies produce antibodies and they are protected 
throughout the flu season, even as antibody levels decline 
over time. People with weakened immune systems may not 
generate the same amount of antibodies after vaccination; 
further, their antibody levels may drop more quickly when 
compared to healthy people.
For everyone, getting vaccinated each year provides the best 
protection against influenza throughout flu season. 
Will this season’s vaccine be a good match for circulating 
viruses? It is not possible to predict with certainty which flu 
viruses will predominate during a given season. Flu viruses are 
constantly changing (called drift) – they can change from one 
season to the next or they can even change within the course 
of one flu season. Experts must pick which viruses to include in 
the vaccine many months in advance in order for vaccine to be 
produced and delivered on time. For more information about 
the vaccine virus selection process visit Selecting the Viruses 
in the Influenza (Flu) Vaccine. Because of these factors, there 
is always the possibility of a less than optimal match between 
circulating viruses and the viruses in the vaccine.
How do we know if there is a good match between the 
vaccine viruses and those causing illness? Over the course 
of a flu season, CDC studies samples of flu viruses circulating 
during that season to evaluate how close a match there is 
between viruses used to make the vaccine and circulating 
viruses. Data are published in the weekly FluView. In addition, 
CDC conducts studies each year to determine how well the 
vaccine protects against illness.
Can the vaccine provide protection even if the vaccine 
is not a “good” match? Yes, antibodies made in response 
to vaccination with one flu virus can sometimes provide 
protection against different but related viruses. A less than 
ideal match may result in reduced vaccine effectiveness against 
the virus that is different from what is in the vaccine, but it can 
still provide some protection against influenza illness.
In addition, it’s important to remember that the flu vaccine 
protects against more than one flu virus, so even when there is 
a less than ideal match or lower effectiveness against one virus, 
the vaccine may protect against the other viruses.
For these reasons, even during seasons when there is a 
less than ideal match, CDC continues to recommend flu 
vaccination. This is particularly important for people at high risk 
for serious flu complications, and their close contacts.
What will CDC do to monitor vaccine effectiveness for the 
2013–2014 season? CDC carries out and collaborates with 
other partners within and outside CDC to assess how well flu 
vaccines work. During the 2013–2014 season, CDC is planning 
multiple studies on the effectiveness of both the flu shot and 
the nasal-spray flu vaccine. These studies will measure vaccine 
effectiveness in preventing laboratory confirmed influenza 
among persons aged 6 months and older. In addition, CDC and 
FDA are monitoring the safety of seasonal influenza and other 
vaccines licensed for use in the United States, in cooperation 
with state and local health departments, health care providers, 
and other partners. Monitoring the safety of seasonal flu 
vaccine in pregnant women is part of this effort.
Two main systems being used to monitor flu vaccine safety are 
VAERS , which is jointly operated with FDA, and the Vaccine 
Safety Datalink (VSD) Project, managed and coordinated by 
CDC’s Immunization Safety Office. Other systems are also being 
used. Through vaccine safety monitoring, CDC and FDA are 
able to quickly identify any clinically significant adverse events 
following immunization that warrant further study or action to 
protect the health of the public.
What is antiviral resistance? Antiviral resistance means that 
a virus has changed in such a way that the antiviral drug is less 
effective in treating or preventing illness. Samples of viruses 
collected from around the United States and worldwide are 
studied to determine if they are resistant to any of the FDA-
approved influenza antiviral drugs.
What will CDC do to monitor antiviral resistance in the 
United States during the 2013–2014 season? CDC routinely 
collects viruses through a domestic and global surveillance 
system to monitor for changes in influenza viruses. CDC will 
continue ongoing surveillance and testing of influenza viruses. 
Additionally, CDC is working with the state public health 
departments and the World Health Organization to collect 
additional information on antiviral resistance in the United 
States and worldwide. The information collected will assist in 
making informed public health policy recommendations.
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Situation Updates
The Centers for Disease Control and Prevention (CDC) is dedicated to protecting health and promoting quality of life 
through the prevention and control of disease, injury, and disability.   CDC works collaboratively with states and local public 
health partners to safeguard communities from public health threats and by identifying and responding to outbreaks of 
infectious diseases.  When states are prepared to detect or respond rapidly to threats, communities are better protected. 
CDC provides technical assistance to states when it is requested by the state.  State and health departments have the ability 
and authority to work with healthcare providers and facilities and with the public to develop, coordinate, and implement 
comprehensive local and regional disease prevention and control strategies in their state or area.
Avian Influenza A (H7N9) Virus
Influenza viruses circulate among humans as the seasonal 
influenza sections describe in this e-brief; however, there are 
influenza viruses which circulate in animals such as birds and 
swine.  These viruses can infect humans, and as happened in 
2009, these viruses can adapt to transmit easily in humans.  
For that reason, CDC remains actively engaged in monitoring 
and responding to the threat posed by these novel animal-
associated influenza viruses.
An outbreak of human infections with a new avian influenza 
A (H7N9) virus was first reported in China by the World Health 
Organization on April 1, 2013. The virus was detected in poultry 
in China as well. During the outbreak, more than 130 human 
infections with H7N9 were reported, the vast majority during 
the month of April. Many of the people infected with H7N9 
reported contact with poultry. The working assumption is that 
human infections occurred after exposure to infected poultry 
or contaminated environments. While some mild illness in 
human cases was seen, most patients had severe respiratory 
illness and 44 people have died. Close contacts of confirmed 
H7N9 patients were followed to determine whether any 
human-to-human spread of H7N9 was occurring. No evidence 
of sustained person-to-person spread of the H7N9 virus was 
found. No cases of H7N9 outside of China have been reported 
and the new H7N9 virus has not been detected in people or 
birds in the United States.
Although the number of cases detected after April fell abruptly, 
studies indicate that avian influenza viruses have a seasonal 
pattern to them, much like human seasonal influenza viruses. 
If this is the case, H7N9 infections – in birds and people – may 
pick up again when the weather turns cooler in China.  Based 
on this previous experience, some limited human-to-human 
spread of this H7N9 virus would not be surprising if the virus 
reemerges in the fall.
 CDC is following this situation closely and coordinating 
with domestic and international partners. CDC takes routine 
preparedness actions whenever a new virus with pandemic 
potential is identified, including developing a candidate 
vaccine virus to make a vaccine if it were to be needed. CDC 
also has issued guidance to clinicians and public health 
authorities in the United States, as well as provided information 
for people traveling to China. CDC will provide updated 
information as it becomes available.
How does one know if symptoms are seasonal influenza, 
H7N9 influenza, or MERS-CoV (Middle Eastern Respiratory 
Syndrome Coronavirus)? Seasonal influenza, H7N9 influenza, 
or MERS-CoV infection can cause similar respiratory symptoms. 
However, of these viruses, your symptoms are most likely 
caused by seasonal influenza. H7N9 and MERS-CoV are less 
common and have not been reported in the United States. At 
this time, H7N9 has only been detected in China. All MERS-CoV 
cases have been linked to countries in or near the  
Arabian Peninsula.
If you are hospitalized for a severe respiratory illness of unknown causes within 10 days of traveling to a country 
where H7N9 has been detected, or you if you have come in 
contact with a patient who is to confirmed to have H7N9 
infection, you may be tested for this disease. If you have 
recently traveled to countries where MERS-CoV has been 
detected and developed a fever, cough or shortness of breath 
within 14 days after returning to the U.S., contact your doctor. 
It is not possible to determine whether a patient has seasonal 
influenza, H7N9 influenza, MERS-CoV infection or illness due 
to another pathogen based on symptoms alone. However, 
there are tests to detect seasonal influenza, H7N9 influenza, 
MERS-CoV infection. Your doctor will determine if you should 
be tested for any of these illnesses based on your symptoms, 
clinical presentation and recent travel history.
At this time, H7N9 has been detected only in China. All MERS-
CoV cases have been linked to countries in or near the  
Arabian Peninsula. 
Check the CDC website for the latest guidance and situation 
updates on these viruses.
CDC Says “Take 3” Actions to Fight  
the Flu
1)    Take time to get a flu vaccine 
2)   Take every day preventative actions to stop the   
 spread of germs 
3)   Take flu antiviral drugs if your doctor  
 prescribes them
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Influenza A (H3N2) Variant Viruses (“H3N2v”) 
Influenza viruses that normally circulate in pigs are called “variant” viruses when they are found in people. Influenza A H3N2 
variant viruses (also known as “H3N2v” viruses) with the matrix (M) gene from the 2009 H1N1 pandemic virus were first detected 
in people in July 2011. The viruses were first identified in U.S. pigs in 2010. In 2011, 12 cases of H3N2v infection were detected in 
the United States (Indiana, Iowa, Maine, Pennsylvania, and West Virginia). In 2012, 309 cases of H3N2v infection across 12 states 
were detected. Reports of H3N2v infections in 2013 began in June with the state of Indiana. CDC works closely with state and local 
health departments to detect and monitor animal origin influenza virus infection of humans. 
These infections have mostly been associated with prolonged exposure to pigs at agricultural fairs. Limited human-to-human 
spread of this virus has been detected in the past as well (Iowa, West Virginia) but no sustained or community spread of H3N2v has 
been identified at this time. The Centers for Disease Control and Prevention (CDC) continues to monitor this situation closely and 
will report cases of H3N2v and other variant influenza viruses weekly in FluView and on the case count tables on this website. CDC 
has developed guidance for the public to protect against H3N2v, and guidance for public health and health care workers.
Partners Play a Vital Role: Special Thanks to CDC’s Partners
CDC acknowledges the significant contributions that partners make to promote and provide flu 
vaccinations and prevent influenza across the United States. The overall success of this vital public health 
service depends on the support of partners at all levels: public health professionals, advocates, medical 
providers, community stakeholders and concerned consumers from across the country.  
At the Partner website, you can find resources and tools, such as coloring books, media toolkits, the Flu 
Vaccine Pledge widget  and a Hispanic motion comic book in Spanish. Un Amor Perdido (A Lost Love) 
is a Spanish language motion comic book based on a true story of a Hispanic couple expecting their 
second child.  Find this and other valuable information at Information for Flu Prevention Partners. 
For more information- on FREE materials, toolkits, mobile content and more - to address flu 
recommendations for Families, Schools and Businesses, Seniors and Young Adults, High Risk 
Populations and the General Public, please visit CDC’s Seasonal Influenza webpage under 
Free Resources. Some content is available in other languages.
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